|
ヒト・動物細胞
|
KP4(RCB1005)
|
64294
|
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose.
|
CPT Pharmacometrics Syst Pharmacol |
2021-5-1 |
Pubmed
Full text
|
